Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating IMVT-1402 for Graves' disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Graves' Disease | Phase 2 | Status: RECRUITING